Bio Green Med Solution Profit Margin

The latest profit margin for BGMS is -213.82% as of June 2026. That compares with 8726.37% in the prior-year period — down 102.5% year over year. That is below the Healthcare sector average of 21.34%. Investors often review this figure alongside Bio Green Med Solution's historical trend and sector peers before judging valuation or financial health.

Over the past year, BGMS's profit margin moved from 8726.37% to -213.82% — a 102.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Bio Green Med Solution's valuation or profitability profile.

Against Healthcare companies, BGMS currently prints -213.82% for profit margin, while the sector average sits near 21.34%. That is roughly 1102.2% below the sector mean. Large gaps often invite a closer look at Bio Green Med Solution's growth, margins, and balance sheet.

Profit Margin shows how effectively Bio Green Med Solution converts resources into returns. At -213.82%, BGMS may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 8726.37% in the prior-year period — down 102.5% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting BGMS's profit margin (-213.82%), review year-over-year change from 8726.37%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.